Archean Chemical Industries Limited share price

NSE: ACI · ISIN INE128X01021

Key numbers

Market cap
₹ 5,957 Cr
Current price
₹ 482.55
52-week high / low
₹ 704 / 446
Stock P/E
59.1
Book value
₹ 156.7
Dividend yield
0.52%
ROCE
7.6%
ROE
5.6%
Debt to equity
0.24
Sales growth (3 yrs)
-9.2%
Profit growth (3 yrs)
-34.6%
1-year return
-31.8%

About Archean Chemical Industries Limited

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales292233255301327
Operating profit7863544467
Net profit4029241331
EPS (₹)3.252.361.921.132.48

Concall summary (2026-08-07)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • EBITDA was INR888.7 million, up 26.3% versus the sequential quarter, with margins expanding from 21.8% in Q4 of FY26 to 25.3% in the quarter under consideration.
  • Realizations are broadly up and we expect them to largely remain firm near the INR300 per kg level.

Growth & demand

  • Firstly, bromine volumes were at the highest in the last five quarters and realizations for the quarter are up 50% year-on-year.
  • The bromine segment delivered revenue of INR1,333 million, up by 58% year-on-year on volumes of 4,175 tons.

Margins & costs

  • In addition to road logistics, sea freight costs have also increased by 30% to 35%, impacting our landed cost to customers in East and South Asia.
  • Acume delivered an EBITDA of INR19 million this quarter against a EBITDA loss of INR27 million in Q1 of last year.

Capex & expansion

  • Our production was up 7% year-on-year despite lower GPL and we also had an impact of around three days of production due to grid power shortages and scheduled maintenance programs which are designed to debottleneck our capacity through the rest of the year.
  • The oilfield chemicals business or Idealis as we call it, revenue was , remained muted and was around INR3.5 million for the quarter as we continue to focus on plant readiness and trial customers' orders.

Balance sheet & cash

  • We continue to focus on a richer, higher value basket and the operating leverage is beginning to show up.
  • And we continue to remain focused on stronger cash flow and more disciplined capital allocation.

Peers in Chemicals

Data for information only, not investment advice. Prices end of day.